Recurrent Osteosarcoma Completed Phase 1 Trials for Oxaliplatin (DB00526)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00101270Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasTreatment